Impact of Theta Burst Stimulation Over the Left DLPFC on Language Switching

Sponsor
Jean-Marie Annoni (Other)
Overall Status
Completed
CT.gov ID
NCT03148470
Collaborator
(none)
41
1
2
33.9
1.2

Study Details

Study Description

Brief Summary

The purpose of this study is to investigate whether theta burst stimulation (TBS) over the left dorsolateral prefrontal cortex (DLPFC) influences language switching and cognitive flexibility. The experimental paradigm will assess the impact of inhibitory and excitatory prefrontal stimulation by TBS versus sham-TBS over the DLPFC in healthy bilinguals.

Condition or Disease Intervention/Treatment Phase
  • Device: Sham iTBS
  • Device: Sham cTBS
  • Device: intermittent theta burst stimulation (iTBS)
  • Device: continuous theta burst stimulation (cTBS)
N/A

Detailed Description

Background:

Clinical observations and neuroimaging studies seem to confirm the role of executive functions and frontal structures in language processing in bilingual subjects.

Repetitive transcranial magnetic stimulation, such as for example theta burst stimulation (TBS), is increasingly being used as a valuable tool for neuroscientists investigating the underlying mechanisms of cognitive functions. Case studies have shown a change in language switching after bilingual patients received repetitive magnetic stimulation to the left DLPFC. However, there is no study investigating the effect of TBS applied to the DLPFC on language switching in healthy participants.

Procedure:

A planned total of 40 unbalanced bilingual participants will be included. Half of the participants will receive inhibitory theta burst stimulation (continuous TBS), the other half excitatory theta burst stimulation (intermittent TBS). After TBS, different language and nonverbal tasks will be performed while an EEG is measured. Before being stimulated, each subject will conduct the same tasks with a sham-TBS as a baseline measure.

Study Design

Study Type:
Interventional
Actual Enrollment :
41 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Impact of Theta Burst Stimulation Over the Left Dorsolateral Prefrontal Cortex on Language Switching and Cognitive Flexibility
Actual Study Start Date :
Sep 1, 2016
Actual Primary Completion Date :
Jul 1, 2018
Actual Study Completion Date :
Jul 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: intermittent theta burst stimulation

intermittent theta burst stimulation (iTBS) + Sham iTBS

Device: Sham iTBS
Placebo stimulation for the iTBS group

Device: intermittent theta burst stimulation (iTBS)
Excitatory theta burst stimulation

Experimental: continuous theta burst stimulation

continuous theta burst stimulation (cTBS) + Sham cTBS

Device: Sham cTBS
Placebo stimulation for the cTBS group

Device: continuous theta burst stimulation (cTBS)
inhibitory theta burst stimulation

Outcome Measures

Primary Outcome Measures

  1. RTs for Picture Naming With the Factors Language (L1, L2) and Block (Switching, Non-Switching) [Within 30 minutes after intervention]

    Picture naming with the factors Language (L1, L2) and Block (Switching, Non-Switching): Speech onset times (msec) L1 refers to the mother tongue. L2 refers to the late acquired (> age 7) second language. Switching Block refers to a language switching block with picture naming alternated between the mother tongue and the second language. Non-Switching Block refers to a block of picture naming either only in the mother or only in the second language.

Secondary Outcome Measures

  1. Nonverbal Switching [Within 30 minutes after intervention]

    Nonverbal Switching: response times

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • L1 (Swiss)German, knowledge of English as a foreign language

  • 18-45 years of age

  • right-handedness

Exclusion Criteria:
  • epilepsy / family history of epilepsy

  • brain surgery, traumatic brain injuries

  • cardiac pacemaker, metallic objects in the head

  • history of neurological diseases or severe psychiatric disorders

  • drug use (alcohol, psychoactive medication)

  • strong headache

  • pregnancy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Laboratory for Cognitive and Neurological Sciences Fribourg Switzerland 1700

Sponsors and Collaborators

  • Jean-Marie Annoni

Investigators

  • Principal Investigator: Jean-Marie Annoni, Prof. Dr., University of Fribourg

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Jean-Marie Annoni, Prof. Dr. med., University of Fribourg
ClinicalTrials.gov Identifier:
NCT03148470
Other Study ID Numbers:
  • SNF325130_156937_4
First Posted:
May 11, 2017
Last Update Posted:
Apr 22, 2020
Last Verified:
Apr 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Jean-Marie Annoni, Prof. Dr. med., University of Fribourg

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title iTBS Group cTBS Group
Arm/Group Description intermittent theta burst stimulation (iTBS) + Sham iTBS Sham iTBS: Placebo stimulation (3 Min) Tasks (30 Min) Pause (10Min) iTBS: Excitatory stimulation (3Min) Tasks (30Min) continuous theta burst stimulation (cTBS) + Sham cTBS Sham cTBS: Placebo stimulation (40Sec) Tasks (30min) Pause (10Min) cTBS: inhibitory stimulation (40 Sec) Tasks (30Min)
Period Title: Overall Study
STARTED 21 20
COMPLETED 20 20
NOT COMPLETED 1 0

Baseline Characteristics

Arm/Group Title Intermittent Theta Burst Stimulation Continuous Theta Burst Stimulation Total
Arm/Group Description intermittent theta burst stimulation (iTBS) + Sham iTBS Sham iTBS: Placebo stimulation intermittent theta burst stimulation (iTBS): Excitatory rTMS continuous theta burst stimulation (cTBS) + Sham cTBS Sham cTBS: Placebo stimulation continuous theta burst stimulation (cTBS): inhibitory rTMS Total of all reporting groups
Overall Participants 21 20 41
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
22.1
(2.7)
22.8
(5.36)
22.4
(4.2)
Sex: Female, Male (Count of Participants)
Female
15
71.4%
16
80%
31
75.6%
Male
6
28.6%
4
20%
10
24.4%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (participants) [Number]
Switzerland
21
100%
20
100%
41
100%

Outcome Measures

1. Primary Outcome
Title RTs for Picture Naming With the Factors Language (L1, L2) and Block (Switching, Non-Switching)
Description Picture naming with the factors Language (L1, L2) and Block (Switching, Non-Switching): Speech onset times (msec) L1 refers to the mother tongue. L2 refers to the late acquired (> age 7) second language. Switching Block refers to a language switching block with picture naming alternated between the mother tongue and the second language. Non-Switching Block refers to a block of picture naming either only in the mother or only in the second language.
Time Frame Within 30 minutes after intervention

Outcome Measure Data

Analysis Population Description
As a primary outcome we compared RTs following iTBS vs cTBS. Sham-TBS is only used to have a baseline control between the two groups
Arm/Group Title RTs for PN After Intermittent Theta Burst Stimulation RTs for PN After Continuous Theta Burst Stimulation RTs for Picture Naming in L1 RTs for Picture Naming in L2 RTs for Picture Naming in the Non-switching Blocks RTs for Picture Naming in the Switching Blocks
Arm/Group Description intermittent theta burst stimulation (iTBS) - across switching and non-switching blocks and across L1 and L2. continuous theta burst stimulation (cTBS) - across switching and non-switching blocks and across L1 and L2. Voice onset times for Picture Naming in L1 - across switching and non-switching blocks and across iTBS and cTBS. Voice onset times for Picture Naming in L2 - across switching and non-switching blocks and across iTBS and cTBS. Voice onset times for Picture Naming in the non-switching blocks - across L1 and L2 and across iTBS and cTBS. Voice onset times for Picture Naming in the switching blocks - across L1 and L2 and across iTBS and cTBS.
Measure Participants 20 20 40 40 40 40
Mean (Standard Deviation) [Milliseconds]
1103.32
(126)
1107.26
(131)
1098.82
(405)
1158.91
(432)
1081.14
(414)
1175.24
(420)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection RTs for PN After Intermittent Theta Burst Stimulation, RTs for PN After Continuous Theta Burst Stimulation, RTs for Picture Naming in L1, RTs for Picture Naming in L2, RTs for Picture Naming in the Non-switching Blocks, RTs for Picture Naming in the Switching Blocks
Comments
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value 0.932
Comments This p-value refers to the effect of stimulation (cTBS vs iTBS).
Method Mixed Models Analysis
Comments
2. Secondary Outcome
Title Nonverbal Switching
Description Nonverbal Switching: response times
Time Frame Within 30 minutes after intervention

Outcome Measure Data

Analysis Population Description
Data are compared between iTBS and cTBS Sham-TBS is only used to have a baseline control between the two groups
Arm/Group Title Intermittent Theta Burst Stimulation Continuous Theta Burst Stimulation
Arm/Group Description intermittent theta burst stimulation (iTBS) continuous theta burst stimulation (cTBS)
Measure Participants 20 20
Mean (Standard Deviation) [Milliseconds]
772.07
(159.28)
739.32
(137.23)
Statistical Analysis 1
Statistical Analysis Overview Comparison Group Selection RTs for PN After Intermittent Theta Burst Stimulation, RTs for PN After Continuous Theta Burst Stimulation
Comments
Type of Statistical Test Other
Comments
Statistical Test of Hypothesis p-Value 0.642
Comments
Method Mixed Models Analysis
Comments

Adverse Events

Time Frame 3 hours
Adverse Event Reporting Description
Arm/Group Title cTBS iTBS Sham iTBS Sham cTBS
Arm/Group Description continuous theta burst stimulation (cTBS) intermittent theta burst stimulation (iTBS) Placebo (baseline) stimulation for iTBS group Placebo (baseline) stimulation for cTBS group
All Cause Mortality
cTBS iTBS Sham iTBS Sham cTBS
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%) 0/21 (0%) 0/20 (0%)
Serious Adverse Events
cTBS iTBS Sham iTBS Sham cTBS
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%) 0/21 (0%) 0/20 (0%)
Other (Not Including Serious) Adverse Events
cTBS iTBS Sham iTBS Sham cTBS
Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/20 (0%) 0/20 (0%) 1/21 (4.8%) 0/20 (0%)
Cardiac disorders
Nausea 0/20 (0%) 0/20 (0%) 1/21 (4.8%) 1 0/20 (0%) 1

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

All Principal Investigators ARE employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Prof. Dr. Jean-Marie Annoni
Organization University of Fribourg
Phone ++4126 306 3802
Email jean-marie.annoni@unifr.ch
Responsible Party:
Jean-Marie Annoni, Prof. Dr. med., University of Fribourg
ClinicalTrials.gov Identifier:
NCT03148470
Other Study ID Numbers:
  • SNF325130_156937_4
First Posted:
May 11, 2017
Last Update Posted:
Apr 22, 2020
Last Verified:
Apr 1, 2020